Suppressive therapy with levothyroxine for solitary thyroid nodules: A double-blind controlled clinical study and cumulative meta-analyses

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 11, 1998, Pages 3881-3885

  Zelmanovitz, Flávio ^a   Genro, Sandra ^a   Gross, Jorge L ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERALIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITOMETRY; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; HORMONAL THERAPY; HUMAN; PRIORITY JOURNAL; THYROID NODULE; TREATMENT OUTCOME;

EID: 0031733918     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.11.3881     Document Type: Article

References (20)

1. Mazzaferri EL. 1993 Management of solitary thyroid nodule. N Engl J Med. 328:553-559.
2. Studer H, Peter HJ, Gerber H. 1989 Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular thyroid growth. Endocr Rev. 10:125-135.
3. Cooper DS. 1995 Clinical review 66: thyroxine suppression therapy for benign nodular disease. J Clin Endocrinol Metab. 80:331-334.
4. Blum M. 1995 Why do clinicians continue to debate the use of levothyroxine in the diagnosis and management of thyroid nodules? (editorial) Ann Intern Med. 122:63-64.
5. Gharib H, James EM, Chaboneau JW, Naessens JM, Offord KP, Gorman CA. 1987 Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med. 317:70-75.
6. Reverter JL, Lucas A, Salinas I, Audi L, Foz M, Sanmarti A. 1992 Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf). 36:25-28.
7. Papini E, Bacci V, Panunzi CM, et al. 1993 A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules. Clin Endocrinol (Oxf). 38:507-513.
8. La Rosa GL, Lupo L, Giufrida D, Gullo D, Vigneri R, Belfiore A. 1995 Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med. 122:1-8.
9. Mainini E, Martinelli I, Morandi G, Villa S, Stefani I, Mazzi C. 1995 Levothyroxine suppressive therapy for solitary thyroid nodule. J Endocrinol Invest. 18:796-799.
10. Lima N, Knobel M, Cavaliere H, Sztejnsznajd C, Tominmori E, Medeiros-Neto G. 1997 Levothyroxine suppressive therapy is partially effective in treating patients with benign solid thyroid nodules and multinodular goiters. Thyroid. 7:691-697.
11. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. 1996 Effects on bone mass of long-term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab. 81:4278-4289.
12. Biondi B, Fazio S, Cuocolo S, et al. 1996 Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. J Clin Endocrinol Metab. 81:4224-4228.
13. Sodestrom N. 1952 Puncture of goiters for aspiration biopsy A preliminary report. Acta Med Scand. 144:235-244.
14. DerSimonian R, Laird N. 1986 Meta-analysis in clinical trials. Controlled Clin Trials. 7:177-188.
15. Berlin JA, Laird NM, Sacks HS, Chalmers TC. 1989 A comparison of statistical methods for combining event rates from clinical trials. Stat Med. 8:141-151.
16. McCowen KD, Reed JW, Fariss BL. 1980 The role of thyroid therapy in patients with thyroid cysts. Am J Med. 68:853-855.
17. La Rosa GL, Ippolito AM, Lupo L, et al. 1996 Cold thyroid nodule reduction with L-thyroxine can be predicted by initial nodule volume and cytopathological characteristics. J Clin Endocrinol Metab. 81:4385-4387.
18. Gharib H, Mazzaferri EL. 1998 Thyroid suppressive therapy in patients with nodular thyroid disease. Ann Intern Med. 128:386-394.
19. LeLorier J, Grégoire G, Benhaddad A, et al. 1997 Discrepancies between meta-analyses and subsequent large randomized controlled trials. N Engl J Med. 337:536-542.
20. Papini E, Petrcci L, Guglielmi R, et al. 1998 Long-term changes in nodular goiter: a five-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab. 83:780-783.